News & Events about 23andme Holding Co.
Globe Newswire
2 months ago
-14 percent of those surveyed say theyre stressed, compared to more than 47 percent in 2020-Under 20 percent of those surveyed said COVID-19 would interfere with their traditional holiday plans; down from 62 percent in 2020-However, most respondents still have some concern about their overall health...
Globe Newswire
2 months ago
The presentation outlines plans for the expansion phase of the study (part B), including the specific tumor indications where 23ME-00610 will be tested for anticancer activitySOUTH SAN FRANCISCO, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human ...
Globe Newswire
3 months ago
Poster to provide details on study design and expansion phase for ongoing Phase 1 study in patients with advanced solid malignanciesSOUTH SAN FRANCISCO, Calif., Oct. 05, 2022 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (23andMe), a leading human genetics and biopharmaceutical company with a...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Missfresh Limited - MF SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Missfresh Limited - MF PR Newswire NEW YORK, July 21, 2022 NEW YORK, July 21, 2022 /PRNewswire/ -- Pomerantz LLP...
Stratos Wealth Partners LTD. boosted its position in 23andMe Holding Co. (NASDAQ:ME Get Rating) by 14.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 34,695 shares of the companys stock after buying an ...